Medical company Acusfoucs has added $21m in capital as it waits for approval from the FDA on its Kamra inlay, which is designed to treat near-vision loss.
AcuFocus, a US-based manufacturer of implants to treating vision loss, has raised $21m from investors incluing medical device maker Medtronic in an oversubscribed round of funding.
Venture capital firms Accuitive Medical Ventures, SV Life Sciences, Versant Ventures and Carlyle Group, and private equity firm Cowen HealthCare Royalty also participated in the round.
AcuFocus develops corneal inlays for treating near-vision loss. The new funding will enable the company to further expand into European markets as it awaits approval for its…
